Required fields are marked with *

Verification code

Carbenoxolone disodium

{PARAM:[Name]}()
Category Orthopoxvirus
CAS 7421-40-1
Description The sodium salt form of Carbenoxolone, which has been found to be an anti-inflammatory glucocorticoid and could inhibit 11β-hydroxysteroid dehydrogenase.
Quotation Now

Product Information

Synonyms (3β,20β)-3-(3-Carboxy-1-oxopropoxy)-11-oxoolean-12-en-29-oic acid disodium
IUPAC Name disodium;(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxylatopropanoyloxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylate
Molecular Weight 614.72
Molecular Formula C34H48Na2O7
Canonical SMILES CC1(C2CCC3(C(C2(CCC1OC(=O)CCC(=O)[O-])C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)[O-])C)C)C)C.[Na+].[Na+]
InChI InChI=1S/C34H50O7.2Na/c1-29(2)23-10-13-34(7)27(32(23,5)12-11-24(29)41-26(38)9-8-25(36)37)22(35)18-20-21-19-31(4,28(39)40)15-14-30(21,3)16-17-33(20,34)6;;/h18,21,23-24,27H,8-17,19H2,1-7H3,(H,36,37)(H,39,40);;/q;2*+1/p-2
InChIKey BQENDLAVTKRQMS-UHFFFAOYSA-L
Boiling Point 687.4°C at 760 mmHg
Flash Point 211.6°C
Purity ≥98% by HPLC
Solubility In Vitro:
H2O : 50 mg/mL(81.34 mM;Need ultrasonic)
DMSO : 16.67 mg/mL(27.12 mM;Need ultrasonic)
In Vivo:
1.Add each solvent one by one:10% DMSO >> 40%PEG300 >> 5%Tween-80 >> 45% saline
Solubility: 1.67 mg/mL (2.72 mM); Clear solution; Need ultrasonic
2.Add each solvent one by one:10% DMSO >> 90%corn oil
Solubility: ≥ 1.67 mg/mL (2.72 mM); Clear solution
3.Add each solvent one by one:10% DMSO >> 90% (20%SBE-β-CDin saline)
Solubility: ≥ 0.93 mg/mL (1.51 mM); Clear solution
Appearance White Solid
Application Anti-Ulcer Agents
Storage 2-8°C
Complexity 1190
Exact Mass 614.31954243
In Vitro Carbenoxolone disodium (6-150 μM; pre-treatment 1 hour) inhibits Vaccinia virus (VACV) replication in a gap junction-independent in HaCaT cells, and it has toxicity effects on VACV-A5L-EGFP infected cells at 48.
Carbenoxolone (30 μM; pre-treatment 1 hour) does not upregulate PP2A expression, but induces the late protein A27 expression in hacat cells.
In Vivo Carbenoxolone (intraperitoneal injection; 100, 200 and 300 mg/kg; 30, 60 and 60 min before Diazepam) does not induce a muscle relaxant activity and shows muscle relaxant activity compared to normal saline, and this effect was more than diazepam in the traction test.
Carbenoxolone (intraperitoneal injection; 100, 200 and 300 mg/kg; 30, 60 and 60 min before Pentylenetetrazole) significantly increases sleeping time and decreases latency in mice as a dose-dependent manner in Pentylenetetrazole (PTZ) Seizure model. The ED50 value is 83.3 mg/kg.
PSA 123.63000
Target Gap JunIC50: human 11β-HSD; bacterial 3α, 20β-HSD; gap junction; Vaccinia virus

TAKE YOUR NEXT STEPS

Get Started With Our Industry Experience And Client-Centric Focus!

Talk to Us

Copyright © 2024 BOC Sciences. All rights reserved.